Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial. Issue 5 (17th May 2018)

• Record Type: Journal Article
• Authors: González-Sarrías, A.; Núñez-Sánchez, M. A.; Ávila-Gálvez, M. A.; Monedero-Saiz, T.; Rodríguez-Gil, F. J.; Martínez-Díaz, Francisco; Selma, M. V.; Espín, J. C.
• Is Part Of: Food & function. Volume 9:Issue 5(2018)
• Page Start: 2617
• Page End: 2622
• Publication Date: 2018-05-17
• Subjects: Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Nutrition -- Periodicals; 664.07
• DOI: 10.1039/c8fo00264a
• Languages: English
• ISSNs: 2042-6496

Abstract

Abstract : Consumption of pomegranate decreases, in a time-dependent fashion, metabolic endotoxemia in patients with newly diagnosed colorectal cancer. Abstract : Gut microbiota dysbiosis alters the intestinal barrier function, increases plasma lipopolysaccharide (LPS) levels, which promotes endotoxemia, and contributes to the onset and development of colorectal cancer (CRC). We report here for the first time the reduction of plasma LPS-binding protein (LBP) levels, a marker of endotoxemia, after pomegranate consumption in newly diagnosed CRC patients.